Skip to main content Skip to main navigation menu Skip to site footer
logo Dermatology Reports

eISSN 2036-7406

  • About the Journal
  • Publication Ethics
  • Editorial Board
  • Current Issue
  • Archives
  • Early Access
  • Register
  • Login
  • Search
  • Contacts

Editor-in-Chief: Carlo Cota, Italy

1.3
Impact Factor 2024
1.5
CiteScore 2024
1.3
Impact Factor 2024
1.5
CiteScore 2024
Submit
an article
  1. Home /
  2. Search

Search

Advanced filters
Published After
Published Before

Search Results

##search.searchResults.foundPlural##
  • Biologics and small molecules treatment for moderate-to-severe atopic dermatitis patients with comorbid conditions and special populations: an Italian perspective

    Alba Guglielmo, Maria Ludovica Deotto , Luigi Naldi , Giuseppe Stinco, Alessandro Pileri, Bianca Maria Piraccini, Anna Belloni Fortina, Andrea Sechi
    13-09-2023
    https://doi.org/10.4081/dr.2023.9839
    2651
    PDF: 968
    HTML: 28
  • Psoriasiform rash possibly induced by oral propranolol in a 12-month-old girl with infantile hemangioma: a case report and literature review

    Sahar Alruhaimi, Fatimah Alowirdi, Waleed Al-Ajroush
    05-03-2025
    https://doi.org/10.4081/dr.2025.10239
    507
    PDF: 307
    HTML: 5
  • Exacerbation of generalized plaque psoriasis after tuberculin test

    Alberto Corrà, Lavinia Quintarelli, Alice Verdelli, Walter Volpi, Marzia Caproni
    28-07-2021
    https://doi.org/10.4081/dr.2021.9019
    3172
    PDF: 490
    HTML: 222
  • Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema

    Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti, Concetta Potenza
    21-11-2022
    https://doi.org/10.4081/dr.2022.9447
    1291
    PDF: 394
    HTML: 44
  • Bacterial colonization of psoriasis plaques. Is it relevant?

    Eva Marcus, Diana Demmler, Andreas Rudolph, Matthias Fischer
    e14
    05-08-2011
    https://doi.org/10.4081/dr.2011.e14
    1665
    PDF: 728
    HTML: 624
  • Guselkumab for the treatment of severe plaque psoriasis in a schizophrenia patient

    Nicoletta Bernardini, Nevena Skroza, Elisabeth Prevete, Federica Marraffa, Ilaria Proietti, Ersilia Tolino, Alessandra Mambrin, Giovanni Rossi, Salvatore Volpe, Giuseppe Bersani, Concetta Potenza
    23-11-2022
    https://doi.org/10.4081/dr.2022.9476
    1352
    PDF: 474
    HTML: 24
  • Infliximab-induced intertriginous psoriasis in patient with Crohn's desease

    Federica Mola, Alberico Motolese
    e40
    03-10-2011
    https://doi.org/10.4081/dr.2011.e40
    1238
    PDF: 584
    HTML: 1070
  • A characterization of the expression of 14-3-3 isoforms in psoriasis, basal cell carcinoma, atopic dermatitis and contact dermatitis

    Line Raaby, Kristian Otkjær, Maria Luise Salvskov-Iversen, Claus Johansen, Lars Iversen
    e14
    14-10-2010
    https://doi.org/10.4081/dr.2010.e14
    4085
    PDF: 820
    HTML: 321
  • The suitability of mesenchymal stem cells for treating immune-mediated inflammatory skin diseases: a systematic review

    Elena Pezzolo, Sara Di Leo, Paola Miceli, Alvise Sernicola, Luigi Naldi
    01-07-2025
    https://doi.org/10.4081/dr.2025.10112
    671
    PDF: 482
    HTML: 6
  • A severe psoriasis flare after COVID-19 treated with risankizumab: complete skin clearance after 16 weeks

    Luciano Ibba, Luigi Gargiulo, Giulia Pavia, Alessandra Narcisi, Antonio Costanzo, Mario Valenti
    06-06-2023
    https://doi.org/10.4081/dr.2023.9722
    779
    PDF: 446
    HTML: 15
  • Possible relationship between poor skin disorders prognosis and serum zinc level: a narrative review

    Mohammed Al Abadie, Zinah Sharara, Miriam Al Abadie, Patrick A. Ball, Hana Morrissey
    06-07-2022
    https://doi.org/10.4081/dr.2022.9512
    2109
    PDF: 996
    HTML: 248
  • Late reaction to ustekinumab infusion

    Marina Resener Morais, Luana Pizarro Meneghello, Carina Flores de Oliveira, André Vicente Esteves Carvalho
    e2
    09-09-2013
    https://doi.org/10.4081/dr.2013.e2
    3948
    PDF: 653
    HTML: 260
  • Psoriasiform syphilis: A challenge

    Antônio Pedro Schettini, José Carlos Sardinha, Elyana Almeida Marques, Cesare Massone
    06-10-2021
    https://doi.org/10.4081/dr.2021.8830
    1503
    PDF: 635
    HTML: 499
  • Evaluation of the glycemic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome: A pilot study

    Tannaz Dehpouri, Ghasem Rahmatpour Rokni, Nematollah Ahangar Narenjbon, Mohamad Goldust, Paul S. Yamauchi, Uwe Wollina, Torello Lotti, Leon Kircik, Vito Giuseppe Di Lernia, Sidharth Sonthalia, Aleksandra Vojvodic, Jacek Szepietowski, Philippe Bahadoran, Enzo Errichetti, Carmen Cantisani, Laura Atzori, Elham Rezaee, Zekayi Kutlubay, Burhan Engin, Steven Nisticò, Giovanni Damiani, Rosalynn R.Z. Conic, Andy Goren, Leo Čabrijan, Georgi Tchernev
    09-05-2019
    https://doi.org/10.4081/dr.2019.7965
    2166
    PDF: 936
    HTML: 919
  • Lentiginous eruption in resolving psoriasis plaques during treatment with ixekizumab: a case report and review of the literature

    Pablo Santa María, Fernando Valenzuela, Claudia Morales, Raul De la Fuente, Roberto Cullen
    11-10-2017
    https://doi.org/10.4081/dr.2017.7079
    1349
    PDF: 647
    HTML: 140
  • Herpes vegetans, an atypical herpes lesion in HIV patient: A case report

    Sondang P. Sirait, Wresti Indriatmi
    14-03-2022
    https://doi.org/10.4081/dr.2022.9180
    2622
    PDF: 793
    HTML: 15
  • Mycobacterium kansasii infection in a psoriasis patient treated with adalimumab and switch to apremilast: First report and literature review

    Alexandra Maria Giovanna Brunasso, Sanja Javor, Emanuele Pontali, Simona Sola, Cesare Massone
    29-07-2021
    https://doi.org/10.4081/dr.2021.8797
    3043
    PDF: 634
    HTML: 8
  • Efficacy and safety of adalimumab biosimilar GP2017 in a 24-month treatment period for plaque psoriasis: real-life experience from Emilia-Romagna centers, Italy

    Marco May Lee, Vito Di Lernia, Francesca Peccerillo, Federico Bardazzi, Michela Tabanelli, Michela Ricci, Davide Melandri, Monica Corazza, Francesca Satolli, Andrea Conti
    01-07-2025
    https://doi.org/10.4081/dr.2025.10315
    482
    PDF: 228
    HTML: 6
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces

    Martina Vispi, Teresa Corradin, Camilla Peccianti, Luca Feci, Laura Casini, Chiara Pisani, Susanna Fabbroni, Paola Corsetti, Margherita Croatto, Michele Pellegrino
    25-06-2020
    https://doi.org/10.4081/dr.2020.8642
    1335
    PDF: 738
    HTML: 3
  • Cumulative life damage in dermatology

    Kristina Ibler, Gregor B.E. Jemec
    e5
    12-04-2011
    https://doi.org/10.4081/dr.2011.e5
    1717
    PDF: 758
    HTML: 90
  • A case of squamous cell carcinoma arising in a giant porokeratosis previously diagnosed as psoriasis

    Lorry Aitkens, Joel Byrne, Charay Jennings-Dover, Kathryn Anne Potter
    29-12-2022
    https://doi.org/10.4081/dr.2023.9634
    904
    PDF: 433
    HTML: 120
  • Linear psoriasis or inflammatory linear verrucous epidermal nevus? A pediatric case unraveling the mosaic puzzle

    Nicolò Rivetti, Camilla Vassallo, Stefania Barruscotti, Valeria Brazzelli, Carlo Francesco Tomasini
    06-06-2025
    https://doi.org/10.4081/dr.2025.10429
    608
    PDF: 294
    HTML: 7
  • Seven cancer patients receiving guselkumab for treatment of moderate-to-severe psoriasis

    Luca Mastorino, Niccolò Siliquini, Gianluca Avallone, Michela Ortoncelli, Pietro Quaglino, Paolo Dapavo, Simone Ribero
    17-03-2022
    https://doi.org/10.4081/dr.2022.9282
    1151
    PDF: 806
    HTML: 40
  • Prevalence of pruritus in the elderly in an outpatient dermatologic clinic: a monocentric pilot study

    Sanja Javor, Luigi Priano, Antonio Anonide, Cesare Massone
    29-08-2023
    https://doi.org/10.4081/dr.2023.9778
    1100
    PDF: 674
    HTML: 30
  • Mucocutaneous presentations of consultant critical and non-critical cases of admitted COVID-19 patients, outpatients, and vaccine-associated dermatoses: a clinical atlas and a large original study of two general COVID-19 centers from Iran

    Afsaneh Sadeghzadeh-Bazargan, Azadeh Goodarzi
    23-05-2023
    https://doi.org/10.4081/dr.2023.9473
    966
    PDF: 448
    SUPPLEMENTARY FILE: 133
    HTML: 21
26 - 50 of 159 items << < 1 2 3 4 5 > >> 

authors

FOR AUTHORS
  • SUBMIT YOUR PAPER
  • Guide for Authors
  • Benefits for Authors
  • How to write a Scientific paper
  • How to write a Review article
  • Article Processing Charge
  • Crediti ECM (Italian Authors)

reviewers

FOR REVIEWERS
  • Benefits for Reviewers
  • How to Review
  • Thanks to Reviewers

Categories

    • XXXI Congresso Nazionale Intergruppo Melanoma Italiano (IMI)
    • IMI - Epidemiology, genetics and pathogenesis
    • IMI - Prevention and diagnosis
    • IMI - Pathological and molecular classification
    • IMI - Surgery
    • IMI - Therapy
    • Newsletter
    • Original Articles
    • Reviews
    • Case Reports

indexing

INDEXING
  • PubMed
  • PubMed Central
  • Scopus
  • DOAJ
  • ESCI
  • Google Scholar
  • OpenAlex
  • Web of Science
  • Analytics

dermatopathology

Dermatopathology

Dermatology Reports

is an Open Access, peer-reviewed journal published by PAGEPress®, Pavia, Italy. All credits and honors to PKP for their OJS.

 

https://godisnjak.pf.unibl.org/

https://revistascientificas.us.es/

pISSN: 2036-7392
eISSN: 2036-7406

Info

  • About
  • Editorial Board
  • News
  • Advertising

Info Submission

  • Submission
  • Guidelines For Authors

Our App Is Free For Anyone!

© PAGEPress 2008-2026    •    PAGEPress® is a registered trademark property of PAGEPress srl, Italy    •    VAT: IT02125780185    •    Privacy